Thiti Susiriwatananont

4PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMolecular targetsClinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 01, 2026
Feasibility and Preliminary Effectiveness of the ChulaCancer Mobile Chatbot for Supportive Care of Patients With Breast or Colorectal Cancer Receiving Chemotherapy: Pilot Randomized Controlled Trial.

|May 07, 2026
The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma.

|Nov 26, 2025
The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists.

Thiti Susiriwatananont, Panuch Eiamprapaporn, Maria Vazquez Roque

|Nov 14, 2025
Clinical Outcomes of HER2-Low Versus HER2-Zero in HR-Positive Metastatic Breast Cancer Treated With Endocrine Therapy With or Without CDK4/6 Inhibitors: A Multicenter Retrospective Study.

Thiti Susiriwatananont, Concord Wongkraisri, Thanate Dajsakdipon

Pageof 1

Frequent Collaborators

3 joint publications

Napa Parinyanitikul

2 joint publications

Nicha Zungsontiporn

2 joint publications

Chanida Vinayanuwattikun

2 joint publications

Piyada Sitthideatphaiboon